Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Ramya Thota

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6538-9924; OpenAlex author ID A5023651022. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper

Papers 3

  1. A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer. First author DOI 10.1097/coc.0000000000000377↗
  2. Preclinical Rationale for the Phase III Trials in Metastatic Pancreatic Cancer: Is Wishful Thinking Clouding Successful Drug Development for Pancreatic Cancer? Co-author DOI 10.1097/mpa.0000000000000753↗
  3. Treatment of metastatic pancreatic adenocarcinoma: a review. Co-author PMID 24683721↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jordan D. Berlin · 3 shared papers, 2014–2018 · strength 0.27
  2. Anirban Maitra · 1 shared paper, 2017 · strength 0.12
  3. Emily W. Chan · 1 shared paper, 2018 · strength 0.09
  4. Dana Backlund Cardin · 1 shared paper, 2018 · strength 0.09
  5. Laura Williams Goff · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.